World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , 

World Journal of Pharmaceutical
and Medical Research

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301

ICV : 78.6



*Dr. Sajal Mahajan (MBBS), Dr. Vishwapriya Kumar (MBBS) and Dr. Manhar Shah (MBBS)(MS)


Adverse drug reactions(ADR) are the most common medical emergency seen in ER. It is essential to know the drugs causing ADR owing to its high rate of hospitalisation leading to high morbidity and mortality. The most common groups of drugs causing ADRs are anti platelet, diuretics, non steroidal anti inflammatory drugs and anticoagulant. A 69 years old male patient presented in ER with multiple blisters on an erythematous base on lower legs since 2 days without any evidence of systemic involvement. Patient gives history of consumption of multiple drugs (anti hypertensives and anti diabetics) amongst which newly consumed drug was Rivaroxaban. It is a factor Xa inhibitor, newly developed anticoagulant used to prevent deep vein thrombosis and atrial fibrillations (AF). So, the final diagnosis of adverse drug eruption secondary to Rivaroxaban consumption was made. We hereby, present you this case for its rarity as rivoroxaban is believed to be the safest of all the anticoagulants with lesser fatal side effects.

[Full Text Article]

Powered By WJPMR | All Right Reserved